Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1502
| Despition | DAG1 Human Recombinant |
| SIZE | 2 µg |
| Purity | Purity as determined by densitometric image analysis is > 90%. |
| Form | Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1307 | NPY2R Blocking Peptide (AC1307) | 250 µg | inquiry |
| ACPP-1620 | Human SIX6 Protein (AC1620) | 5 µg | inquiry |
| ACPP-1783 | Human SAT2 Protein (AC1783) | 5 µg | inquiry |
| ACPP-1564 | Human EIF3K Protein (AC1564) | 2 µg | inquiry |
| ACPP-1795 | Human STXBP6 Protein (AC1795) | 5 µg | inquiry |
| ACPP-1432 | Human NENF Protein (AC1432) | 2 µg | inquiry |
| ACPP-1073 | Dopamine D5 Receptor Blocking Peptide (AC1073) | 250 µg | inquiry |
| ACPP-1049 | Recombinant Human Galectin 3 Protein (6×His Tag) (AC1049) | 50 µg | inquiry |
| ACPP-1168 | KCNJ5 Blocking Peptide (AC1168) | 250 µg | inquiry |
| ACPP-1787 | Exenatide (AC1787) | 1 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.